期刊文献+

在胆管癌组织中检测p53,p21^(WAF1)的表达 被引量:3

Detection of p53 and p21^(WAF1) in cholangiocarcinoma
原文传递
导出
摘要 目的 研究胆管癌中p5 3,p2 1WAF1基因表达以及它们之间的关系 ,以期为找到一种早期诊断及判断胆管癌预后的方法打下一个基础。方法 本研究采用 30例人胆管癌及癌旁组织配对资料 ,应用原位杂交及免疫组化方法检测p5 3 ,p2 1WAF1基因表达并探讨它们之间的关系 ,进而分析它们与临床病理资料之间的相关性。结果 原位杂交检测 30例胆管癌中有 14例 (14/30 ,46 7% )呈p5 3阳性 ,12例 (12 /30 ,40 0 % )p2 1WAF1阳性。p5 3,p2 1WAF1原位杂交结果与胆管癌的临床病理资料无明显相关性。免疫组化检测 30例胆管癌中 ,P5 3蛋白阳性 16例 (16 /30 ,5 3 3% ) ,P2 1WAF1阳性 11例 (11/30 ,36 7% )。有局部淋巴结转移组P5 3基因蛋白表达阳性率明显高于无局部淋巴结转移组 ;临床Ⅲ期的病人P5 3蛋白阳性率明显高于临床Ⅰ和Ⅱ期的病人。并且有P5 3蛋白表达的病人其生存期明显短于无P5 3蛋白表达的病人。p2 1WAF1亦与病人的生存期有关 ,存在p2 1WAF1表达的病人其生存期明显长于无p2 1WAF1表达的病人。结论 胆管癌中P5 3,P2 1WAF1蛋白表达与预后密切相关 ,提示二者可能在胆管癌的发展过程中起到重要作用。p5 3,p2 1WAF1之间未见明显相关性 ,说明可能存在非p5 3依赖的p2 Objective To clarify the clinical significance of p21 WAF1 and the relationship between it and p53. Methods Samples of human cholangiocarcinoma (HC) tissue and paired normal bile duct tissue adjacent to the tumor from 30 patients with HC were employed in this study. In situ hybridization (ISH) was used to detect the p53 and p21 mRNA expression. Immunohistochemistry (IHC) was applied to analyze p53 gene mutation and P21 protein expression. Results p21 WAF1 And p53 gene protein expression was detected in 36.7% (11/30) and 53.3% (16/30) of the carcinoma specimens, respectively, and none of the paired tissue by IHC. p53 Positivity was related to local lymph node metastasis. Comparing with non-lymph node metastatic group, p53 positivity in metastatic group was significantly higher. p53 Positivity of cholangiocarcinoma in clinical stage III was significantly higher than that in clinical stages I and II. The survival time was significantly shorter in patients with P53 protein expression than in those without. It was found that p53 expression was not associated with p21 WAF1 expression. Conclusions P53 Positivity may be correlated with tumor development but not tumor occurrence. The fact that p53 expression was not associated with p21 WAF1 expression indicates that p53-independent activation of p21 WAF1 may exist.
出处 《中华肝胆外科杂志》 CAS CSCD 2000年第6期442-446,共5页 Chinese Journal of Hepatobiliary Surgery
基金 国家杰出青年基金资助
关键词 胆管癌 P53基因 P21^WAF1基因 基因表达 Gene p53 Gene p21 WAF1 Cholangiocarcinom€
  • 相关文献

参考文献10

  • 1Marchetti A,Butitta F,Merlo G,et al.p53 Alterations in nonsmall cell lung cancers correlate with metastatic involvement of hilar and mediastinal lymph nodes[].Cancer Research.1993
  • 2Jakus J,Yeudall WA.Growth inhibitory concentrations of EGF induce p21(WAF1/Cip1) and alter cell cycle control in squamous carcinoma cells[].Oncegene.1996
  • 3Ohue M,Tomita N,Monden T,et al.A frequent alteration of p53 gene in carcinoma in adenoma of colon[].Cancer Research.1994
  • 4Finlay CA,Hinds PW,Tan T-H,et al.Activating mutations for transformation by p53 produce a gene product that forms and hsc 70- p53 complex with an altered half-life[].Molecular and Cellular Biology.1988
  • 5Miller CW,Wimor K,Ablo A,et al.p53 Mutations in human lung tumors[].Cancer Research.1992
  • 6Ryberg D,Kure E,Lystad S,et al.p53 Mutations in lung tumors: relationship to putative susceptibility markers for cancer[].Cancer Research.1994
  • 7Hall P,Lane DP.p53 In tumor pathology: can we trust immunohistochemistry? -revisited[].Journal of Paleopathology.1994
  • 8DiGiuseppe JA,Redston MS,Yeo CJ,et al.p53-Independent expression of the cyclin-dependent kinase inhibitor p21 in pancreatic carcinoma[].American Journal of Pathology.1995
  • 9Roncalli M,Patriarca C,Gambacorta M.Expression of new phenotypic markers in cholangiocarcinoma and putative precursor lesions[].Surgical Oncology.1993
  • 10Dergham ST,Dugan MC,Joshi US,et al.The clinical significance of p21 WAF1 /CIP-1 and p53 expression in pancreatic adenocarcinoma[].Cancer.1997

同被引文献45

  • 1Noushin Taghavi,Firouzeh Biramijamal,Masoud Sotoudeh,Omeed Moaven,Hooman Khademi,Mohammad Reza Abbaszadegan,Reza Malekzadeh.Association of p53/p21 expression with cigarette smoking and prognosis in esophageal squamous cell carcinoma patients[J].World Journal of Gastroenterology,2010,16(39):4958-4967. 被引量:10
  • 2闫朝岐,杨维良.胆管癌基因研究现状及展望[J].中华实验外科杂志,2005,22(11):1413-1414. 被引量:5
  • 3张国梁,迟宝荣,任旭.胆管癌的K-ras和p53基因研究进展[J].吉林大学学报(医学版),2006,32(1):168-171. 被引量:6
  • 4许春森,殷凤峙,陈大良.胆管癌、胆囊癌C-erbB-2蛋白表达及其临床意义[J].中华实验外科杂志,1996,13(4):203-204. 被引量:6
  • 5Teh M, Wee A, Raju GG. An immunohistochemical study of p53 protein in gallbladder and extrahepatic bile duct/ampullary carcinomas [ J]. Cancer,1994,74(5) : 1542-1545.
  • 6Chow NH,Huang SM,Chan SH,et al. Significance of e-erb B-2 expression in normal and neoplastic epithelium of biliary tract[J]. Anticancer Res, 1995, 15 (3) : 1055-1060.
  • 7Collier JD, Guo K, Mathew J, et al. c-erbB-2 oncogene expression in hepatocellular carcinoma[ J ]. J Hepatol, 1992,14 (2) :377-380.
  • 8Li R, Sutphin PD, Schwartz D, et al. Mutation p53 protein expression interferes with p53-independent apoptotic pathways[J]. Oncogene, 1998, 16: 3269-3277.
  • 9Lee JC, Lin PW, Lin YJ, et al. Analysis of K-ras gene mutations in periampullary cancers, gallbladder cancers and cholangiocarcinomas from paraffin-embedded tissue sections[J]. J Formos Med Assoc, 1995, 94 (12):719-723.
  • 10Matsubara T, Sakurai Y, Sasayama Y, et al. K-ras point mutations in cancerous and noncancerous biliary epithelium in patients with pancreaticobiliary maljunction [J]. Cancer,1996, 77 (8): 1752-1757.

引证文献3

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部